La catena delle opzioni mostra i dati chiave delle opzioni azionarie di SenesTech a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per SenesTech..

SenesTech (NASDAQ:SNES) Azioni, Catena delle Opzioni

SENESTECH INC

SenesTech

SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.

SenesTech Inc

Gevo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) announced Wednesday that it has <a href="https://www.benzinga.com/pressreleases/25/04/g44710157/gevo-and-future-energy-global-sign-saf-scope-1-and-scope-3-voluntary-carbon-credit-offtake-agreeme" target="_blank" rel="noreferrer noopener">entered a multi-year offtake agreement</a> with Future Energy Global (FEG) to supply carbon abatement credits tied to 10 million gallons per year of sustainable aviation fuel (SAF).
The agreement enables airlines and corporations to reduce their Scope 1 and Scope 3 emissions. The deal includes an option for FEG to increase the offtake volume in the future.
The deal is expected to support Gevo's financing of its ATJ-60 production facility in Lake Preston, South Dakota. Backed by a $1.63 billion conditional loan guarantee from the U.S. Department of Energy and equity from project-level investors, the plant is designed to produce 60 million gallons of low-emission SAF annually at a cost comparable to conventional jet fuel.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/guidance/25/02/43442930/gevo-buys-ethanol-ccs-assets-secures-additional-100-million-potential-funding-for-net-zero-north-expansion" rel="noreferrer noopener">Gevo Buys Ethanol &amp; CCS Assets, Secures Additional $100 Million Potential Funding For Net-Zero North Expansion</a>
With global aviation targeting net-zero emissions by 2050—and SAF projected to deliver two-thirds of the required reductions—production must scale over 400-fold. FEG addresses this challenge by offering SAF-derived Scope 1 and Scope 3 credits to buyers who can't access physical fuel, using a "Book and Claim" model that separates environmental attributes from fuel logistics to reduce costs and emissions.
Gevo CEO Dr. Patrick Gruber emphasized that a functional Book and Claim market can help unlock faster SAF adoption, including for aircraft lessors who own nearly half the global commercial fleet.
By commercializing SAF-related carbon credits and offering predictable pricing, FEG's business model helps bridge financing gaps, enabling suppliers like Gevo to expand more rapidly. While its initial focus is aviation, FEG's credit solutions extend to the marine and land transport sectors.
Price Action: GEVO shares are trading lower by 0.98% at $1.01 at the last check Wednesday.
Photo: Shutterstock

News

GEVO

Gevo Seals SAF Offtake With FEG, Backed By DOE Loan And Net-Zero Industry Momentum

U.S. Treasury Secretary Scott Bessent has signaled <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44610530/strategic-bitcoin-embrace-by-us-could-trigger-global-crypto-policy-shift-says-grayscale">a major policy shift</a> toward fostering innovation in financial technology, saying the Trump administration will "take a close look at regulatory impediments to blockchain, stablecoins and new payment systems."
What Happened: The <a href="https://x.com/DocumentingBTC/status/1909962480958218540">remarks</a> came during his keynote address at the American Bankers Association conference in Washington.
The statement marks the clearest indication yet that the U.S. Treasury is preparing to reassess the regulatory landscape around decentralized technologies and digital financial infrastructure.
"We will consider reforms to unleash the awesome power of the American capital markets," Bessent said. "Americans deserve a financial services industry that works for all Americans, including and especially Main Street. Under President Trump's leadership, the Treasury Department and I will deliver that to you."
The announcement comes at a time when the administration is recalibrating its stance on both domestic financial regulation and international trade strategy.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44708344/21shares-launches-dogecoin-fund-backed-by-dogecoin-foundation">21Shares Launches Dogecoin Fund Backed By Dogecoin Foundation</a>
Why It Matters: In a Q&amp;A <a href="https://www.bloomberg.com/news/articles/2025-04-09/bessent-sees-a-deal-with-allies-then-group-approach-on-china">session</a> following his speech, Bessent shifted to trade policy, outlining a plan to coordinate with U.S. allies on a unified economic approach toward China.
He acknowledged that while America's military relationships with its allies have been strong, economic cooperation has not always kept pace.
"They've been good military allies, not perfect economic allies. But we can probably reach a deal with our allies," Bessent said. "Then we can approach China as a group."
He issued a sharp warning to the European Union, which recently announced tariffs on approximately €21 billion ($23.2 billion) of U.S. goods in response to metal-related disputes. 
In particular, Bessent criticized signs of an EU pivot toward Beijing, noting that such a move "would be cutting your own throat."
Bessent emphasized that China stands alone in escalating trade tensions with the U.S., while several Indo-Pacific countries, including Japan, Vietnam, South Korea, and India, have initiated or expressed interest in trade negotiations with Washington. 
A Vietnamese delegation is scheduled to arrive in D.C. this week, he noted.
Bessent also addressed recent moves by the People's Bank of China, which has allowed the yuan to weaken for five consecutive sessions, pushing the currency to its lowest offshore level since the market was established in 2010. 
In a Fox Business interview, Bessent labeled China as "the worst offenders in the international trading system."
"What Beijing should not do is try to devalue their way out of this," he said, warning that such a move could trigger a chain reaction. "Any devaluation campaign would spur the rest of the world to keep raising their tariffs to offset the devaluation."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44708153/xrp-will-overtake-ethereum-by-2028-standard-chartered">XRP Will Overtake Ethereum By 2028: Standard Chartered</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Treasury Secretary Bessent: Trump Admin Will Take A Close Look At Impediments To Blockchain, Stablecoins'

Warner Bros. Discovery Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) is facing geopolitical headwinds as the U.S.–China trade war escalates, with Beijing retaliating against Washington&#8217;s recent tariff hikes by <a href="https://www.benzinga.com/25/04/44708618/china-retaliates-with-massive-84-tariff-hike-on-us-goods-amid-escalating-trade-war">increasing its own levies</a> on U.S. goods from 34% to 84%. As of Wednesday morning, WBD stock is trading lower by 23.8% to $7.64 over the trailing week.
What To Know: This move, announced by China's Ministry of Commerce and accompanied by new export controls and a World Trade Organization complaint, signals rising pressure on U.S. companies operating in China—<a href="https://www.benzinga.com/25/04/44708103/why-investors-should-watch-chinas-service-trade-amid-us-tariff-escalation-disney-and-imax-most-impacted">including those in the media and entertainment sectors</a>.
Among the most concerning retaliatory measures is a proposed restriction or outright ban on U.S.-made films, a serious threat to Warner Bros. Discovery, which holds numerous international licensing deals in China. Hollywood films grossed under $600 million in China's $17.7 billion box office in 2024, but this revenue remains crucial for studios like WBD. 
For Warner Bros. Discovery, China has long represented a strategic growth market for its blockbuster films and global content brands, making any potential restrictions a significant blow to its international ambitions.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44710975/wall-streets-american-exceptionalism-trade-falters-as-dollar-stocks-bonds-all-slide">Wall Street&#8217;s &#8216;American Exceptionalism&#8217; Trade Falters As Dollar, Stocks, Bonds All Slide</a>
<h2 class="wp-block-heading">How To Buy WBD Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Warner Bros. Discovery&#8217;s case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, WBD has a 52-week high of $12.70 and a 52-week low of $6.64.

What's Going On With Warner Bros. Discovery (WBD) Stock?

JD.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>), one of China's largest e-commerce giants, is experiencing heightened volatility once again Wednesday following China's announcement of a sharp increase in retaliatory tariffs on U.S. goods. The stock is now lower by some 15% to $33.31 over the trailing week.
What To Know: On Thursday, Beijing will <a href="https://www.benzinga.com/25/04/44708618/china-retaliates-with-massive-84-tariff-hike-on-us-goods-amid-escalating-trade-war">raise tariffs</a> from 34% to 84% in response to a 104% U.S. tariff hike that took effect Wednesday. The move intensifies the already fraught trade war between the two economic superpowers and creates fresh uncertainty for companies like JD.com that are <a href="https://www.benzinga.com/25/04/44708103/why-investors-should-watch-chinas-service-trade-amid-us-tariff-escalation-disney-and-imax-most-impacted">deeply integrated</a> into global supply chains.
As a major player in retail and logistics, JD.com relies on the steady flow of imported goods and international partnerships, which may now face disruption. China&#8217;s Ministry of Commerce also escalated tensions by <a href="https://www.benzinga.com/25/04/44708618/china-retaliates-with-massive-84-tariff-hike-on-us-goods-amid-escalating-trade-war">blacklisting</a> six U.S. firms and filing a formal complaint with the WTO. 
For JD, which operates a tech-heavy, logistics-driven model, increased trade barriers could impact both consumer prices and fulfillment operations.
Read Also: <a href="https://www.benzinga.com/25/04/44710071/delta-air-lines-q1-flies-past-expectations-grounds-fy25-outlook-amid-economic-uncertainty">Delta Air Lines Wants To Protect Margins And Cash Flow Citing Economic Uncertainty, Does Not Reaffirm FY25 Outlook</a>
<h2 class="wp-block-heading">How To Buy JD Stock</h2>
By now you're likely curious about how to participate in the market for JD.Com &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of JD.Com which is trading at $33.29 as of publishing time, $100 would buy you 3.0 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JD.Com has a 52-week high of $47.82 and a 52-week low of $24.13.

What's Going On With JD.Com Stock Wednesday?

Kevin O'Leary isn't a fan of <a href="https://www.benzinga.com/markets/25/04/44656898/market-mayhem-persists-as-tariffs-spark-turmoil-experts-say-dont-panic">market drops</a>—but he's not running from them either. The investor and TV personality says corrections are just part of the deal when it comes to long-term investing.
<h2 class="wp-block-heading">Focus on the Outcome, Not the Drama</h2>
"I hate volatility and I don't like it when the market corrects," O'Leary recently said. "But the market corrects all the time and it generally goes down 15% to 20%. It's proven over 100 years plus."
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/vatom-adv">Invest in the Future of Digital Engagement. Own a Piece of the $100 Billion Metaverse Today for Just $500.</a></li>
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.55 per share now</a>.</li>
</ul>
Instead of panicking, he sees pullbacks as opportunities. "It's a <a href="https://www.benzinga.com/markets/equities/25/04/44631713/tariffs-will-provide-great-buying-opportunity-in-long-term-investors-must-first-cross-stagflatio">great buying opportunity</a>," he said, pointing to recent jobs numbers and a solid economy as proof things aren&#8217;t as bad as headlines suggest.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I try to focus on the signal, not the noise. We&#39;ve got 60 countries on the list. Already, you&#39;ve heard from Thailand, Cambodia, the EU, and Senator Kennedy of Louisiana calling for zero tariffs between Canada and the United States. The whole point is it&#39;s a negotiation, and if… <a href="https://t.co/MbPZGxqmTk">pic.twitter.com/MbPZGxqmTk</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1908656664167014544?ref_src=twsrc%5Etfw">April 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h2 class="wp-block-heading">Scaramucci Points Out Hypocrisy</h2>
In the same <a href="https://transcripts.cnn.com/show/lcl/date/2025-04-04/segment/01">CNN interview</a>, former White House Director of Communications Anthony Scaramucci, pushed back on O&#8217;Leary, raising concerns about what O&#8217;Leary would say if this happened under a Kamala Harris administration.&nbsp;
&#8220;If 80 days into the Harris administration, we drop $10 trillion of market capitalization, and all of our trading partners lost faith in us, Kevin would be having a heart attack,&#8221; he said.
Despite the jab, O&#8217;Leary stood by his stance, responding, "Harris is not president. Trump is. And if you didn&#8217;t like him 12 years ago, you don&#8217;t like him now. I get it. But that&#8217;s not the issue.&#8221;
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
<h2 class="wp-block-heading">Buying When It Feels Worst</h2>
Speaking with <a href="https://www.youtube.com/watch?v=qX1pZvus5Uo">Yahoo Finance</a> last month, O'Leary shared a similar sentiment. "Nobody likes volatility," he said. "But as an investor, you learn that you have to hold your nose. And when there&#8217;s blood in the streets, you have to be buying."
He <a href="https://www.benzinga.com/news/25/03/44408147/kevin-oleary-says-nobody-likes-volatility-but-investors-must-hold-their-nose-and-buy-when-theres-blood-in-the-streets">pointed to the Nasdaq</a>, where some stocks were already down 30% to 40%, and the Russell 2000, which he says is full of undervalued companies. Rather than chasing individual names, he's been buying index funds.
"I bought more because it's on sale," he said.
O'Leary added that trying to time the bottom is a waste of energy. "Never think you're going to catch the bottom. I don&#8217;t even guess to do that. I don&#8217;t try and time the market."
See Also: <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">With Shares Starting at Just $1.52, This Could be Your Chance to Invest in the Future of Healthcare.</a>
<h2 class="wp-block-heading">Backing Trump on Tariffs</h2>
O'Leary also addressed President Donald Trump's tariff push, which has drawn criticism in recent weeks. He argued that the tariffs are tools for negotiation and that Trump's approach is aimed at reaching fairer trade deals.
"You have to think of them as negotiating tools of economic warfare," he said. "If you can get to zero tariffs, that's the best outcome. That's called free trade."
He said the US is now in discussions with around 60 countries and already seeing movement from places like Thailand, Cambodia, the European Union and even Sen. John Kennedy (R-LA), who <a href="https://www.kennedy.senate.gov/public/press-releases?ID=39C792B7-8579-4F78-9862-E40970DE4448">called for</a> zero tariffs between Canada and the US.
Despite the noise, O'Leary says the underlying data tells a different story. "We just got the jobs numbers. The economy is just fine," he said.
At the end of the day, O'Leary says he's focused on results, not headlines. "Maybe you don&#8217;t like watching sausage being made. Obviously, Trump doesn&#8217;t care. He&#8217;s an unusual character that way. But I don&#8217;t care about the noise, I care about the outcome."
Read Next:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
</ul>

Kevin O'Leary Says, 'I Hate Volatility And I Don't Like It When The Market Corrects—But The Market Corrects All The Time, Up To 20%'

Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) shares are trading higher premarket on Wednesday. The company launched its most powerful and versatile battery to date, the IQ Battery 5P with FlexPhase, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/g44708775/enphase-energy-expands-in-europe-with-iq-battery-5p-with-flexphase-delivering-three-phase-backup-p" rel="noreferrer noopener">for customers in Poland</a>.
This all-in-one AC-coupled system offers reliable backup power and supports both single-phase and three-phase setups, providing flexible energy solutions for various home needs.
The FlexPhase battery was recently introduced in Germany, Austria, Switzerland, and Luxembourg.
The IQ Battery 5P starts with 5 kWh of capacity and can be scaled up to 70 kWh using multiple units.
Each 5 kWh battery delivers up to 3.68 kW of continuous power in single-phase setups and 1.28 kW per phase in three-phase setups.
Designed for flexibility, it supports both grid-tied and backup power configurations.
When paired with the IQ System Controller 3 INT, it can deliver up to twice its continuous power for three seconds to start high-power devices without grid support.
In Poland, the battery comes with a 15-year industry-leading warranty.
Szymon Konieczka, CEO of BTI Solar, an installer of Enphase products in Poland, stated, &#8220;What sets this technology apart is its adaptability – the battery&#8217;s scalable architecture accommodates both single-phase and three-phase systems, letting us customize backup solutions for each home. Enphase continues to be an industry leader with innovations like this.&#8221;
Sabbas Daniel, senior vice president of sales at Enphase Energy, said, &#8220;With its compatibility for both single-phase and three-phase systems, the IQ Battery 5P is ideally suited for retrofitting the country&#8217;s large base of existing solar homes.&#8221;
On Tuesday, the company disclosed the launch of its most powerful and flexible battery to date, the IQ Battery <a href="https://www.benzinga.com/news/contracts/25/04/44694476/enphase-unveils-advanced-three-phase-iq-battery-in-luxembourg-with-15-year-warranty" target="_blank" rel="noreferrer noopener">5P with FlexPhase, in Luxembourg</a>.
Investors can gain exposure to the stock via&nbsp;Invesco Solar ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAN#NYSE">TAN</a>) and&nbsp;Global X Solar ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYS#NASDAQ">RAYS</a>).
Price Action: ENPH shares are down 1.75% at $48.65 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44697600/stocks-rebound-chipmakers-soar-on-trade-deal-hopes-bitcoin-lags-whats-driving-markets-tuesday" target="_blank" rel="noreferrer noopener">Stocks Rebound, Chipmakers Soar On Trade Deal Hopes, Bitcoin Lags: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

ENPH

RAYS

Enphase Rolls Out Scalable, Grid-Ready IQ Battery 5P in Poland With 15-Year Warranty

As tariffs and trade war chatter send shivers down tech's spine, Stephanie Link of Hightower Advisors sees opportunity &#8211; especially in software and services names with recurring revenue and minimal exposure <a href="https://www.benzinga.com/topic/tariffs">to global shocks</a>.
"This actually signals a decent time to buy if you're a long-term shareholder," she said, pointing to three tech heavyweights she's adding to this week: Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) and Palo Alto Networks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>).
<h2 class="wp-block-heading">Meta's AI Moat Is Still Wide</h2>
Meta might be down 33% from its highs, but Link views the slump as a gift. At 20x earnings, the stock looks cheap given its 20% total revenue growth and commanding 40% operating margins. 
With 3.3 billion users and $85 billion earmarked for AI spending this year alone, Meta's scale and automated ad growth—up 77% to $20 billion last quarter—make it a core AI beneficiary with limited tariff risk.
Read Also: <a href="https://www.benzinga.com/general/social-media/25/04/44704723/meta-restricts-live-streaming-for-teens-under-16-as-part-of-expanded-safety-measures">Meta Restricts Live Streaming For Teens Under 16 As Part Of Expanded Safety Measures</a>
<h2 class="wp-block-heading">IBM's Quiet Reinvention Pays Off</h2>
IBM, meanwhile, has been reshaping itself under CEO Arvind Krishna. With only 1% exposure to reciprocal tariffs (compared to Apple Inc's (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) 43%), IBM has leaned into software and services, which now make up 75% of its revenue mix. 
The company is on a deal spree &#8211; 39 acquisitions in AI, data center, blockchain and cloud—signaling aggressive transformation.
<h2 class="wp-block-heading">Palo Alto Networks: Cybersecurity's Crown Jewel</h2>
And then there's Palo Alto, where Link sees an even bigger trend than AI &#8211; cybersecurity. Palo Alto's next-gen security offerings are growing 30% annually, and its firewall business is holding strong in double digits. 
With consolidation driving demand for platform solutions and free cash flow margins at 37%, Link says it's a must-own in a sector where bigger is better.
For Link, it's all about sticking with resilient business models that don't flinch in the face of tariffs or tech turmoil. As uncertainty rattles markets, her picks reflect a clear theme &#8211; betting on scalable, software-heavy giants that are quietly winning the long game.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44683681/exclusive-metas-still-the-mag-7-standout-says-expert-but-can-it-hold-on" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Meta&#8217;s Still The Mag 7 Standout, Says Expert &#8211; But Can It Hold On?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Long Ideas

Analyst Ratings

Tech

Trading Ideas

AAPL

PANW

Meta, IBM, Palo Alto Networks: Why Stephanie Link Is Doubling Down On These Tariff-Proof Tech Titans

Germany's newly formed CDU/CSU-SPD coalition will not roll back the country's <a href="https://www.benzinga.com/markets/cannabis/24/10/41336543/is-germany-set-to-become-next-cannabis-giant-we-tripled-within-one-year-says-industry-insider">cannabis legalization law</a>, known as CanG, despite internal pressure from Bavaria's conservative leadership. Instead, the government will proceed with a scheduled evaluation of the policy in late 2025, leaving the current legal framework unchanged for now.
The decision marks a significant moment for Europe's largest economy, which became one of the most progressive <a href="https://www.benzinga.com/topic/germany-cannabis">cannabis markets</a> on the continent when it removed cannabis from the country's Narcotics List in 2024. As of April 1, 2024, adults in Germany are permitted to cultivate, possess and consume limited amounts of cannabis for personal use. Since July 1, 2024, individuals have also been able to apply to form cannabis cultivation associations under strict guidelines.
According to <a href="https://internationalcbc.com/germanys-coalition-decides-no-changes-to-cang-law-for-now">ICBC</a>, "no changes to the law are reportedly being made right now, although future evaluations will occur as part of the coalition agreement."
<h2 class="wp-block-heading">Coalition Talks Spark Debate, But End In Compromise</h2>
As <a href="https://www.mdr.de/nachrichten/deutschland/politik/cannabis-legalisierung-ruecknahme-koalitionsvertrag-100.html">MDR Aktuell</a> reported, the reversal of cannabis legalization "is not included in the coalition agreement of the Union and SPD." This outcome represents a compromise between factions within the new black-red coalition, particularly following weeks of lobbying by the Christian Social Union (CSU) to reinstate prohibition.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/04/44633602/why-cannabis-accessory-brands-are-rushing-to-expand-globally">Why Cannabis Accessory Brands Are Rushing To Expand Globally</a>
"The CSU had pushed for this during coalition negotiations but was unable to prevail," MDR noted. While the coalition agreement does not eliminate legalization, it does include a commitment to assess the policy's effects. The agreement states that there will be "a neutral evaluation of the law on the legalization of cannabis" beginning in autumn 2025, with results expected the following year.
Bavaria's Interior Minister Joachim Herrmann voiced his opposition just days before the coalition agreement was finalized. "We want to reverse the mistake made by the traffic light coalition and ban cannabis again," Herrmann told the Augsburger Allgemeine. He added that interior ministers across party lines agreed on this position and called the belief that legalization would weaken criminal networks "completely deceptive."
The CDU, by contrast, adopted a less combative tone. CDU parliamentary group vice chair Thorsten Frei stated in early March that cannabis was "not a focus for the CDU" during negotiations. This opened the door for a policy compromise.
SPD leaders largely remained silent during coalition talks. However, Germany's federal drug commissioner, Burkhard Blienert of the SPD, later defended the existing law. "It has made an important contribution to a more honest and decriminalized approach to drugs," he told Bayern Mediengruppe newspapers. Blienert added that Germany needs "an addiction policy that protects, helps and supports, and is not based on assumptions and prejudices." He encouraged waiting for the evaluation results before considering changes.
<h3 class="wp-block-heading">Bavaria Maintains A Hardline Position</h3>
Although the national law remains in effect, Bavaria continues to pursue restrictive cannabis policies at the state level. Health Minister Judith Gerlach said that "not a single permit has been issued so far" for cannabis cultivation associations in Bavaria, making it the only German state without legal cultivation beyond private homes. "The legalization of cannabis for recreational purposes must now be quickly and completely reversed," Gerlach stated to the Augsburger Allgemeine.
Had the CDU/CSU succeeded in including a rollback in the coalition deal, it could have forced the dissolution of legal cannabis clubs in states like Saxony, Saxony-Anhalt and Thuringia, where associations have already been licensed. For now, those clubs remain legal.
<h2 class="wp-block-heading">Medical Sector And Research See Continued Gains</h2>
One of the most transformative elements of the CanG law—removing cannabis from the Narcotics List—remains untouched. According to ICBC, the change "drastically improved safe access to medical cannabis in Germany, made the medical cannabis supply chain more efficient, and removed some of the barriers to medical cannabis research."
Germany's legalization model also includes ongoing pilot trials for cannabis sales in specific municipalities, with more than two dozen applications under review.
Meanwhile, some medical professionals continue to express concern. German Medical Association president Klaus Reinhardt told the Neue Osnabrücker Zeitung that legalization threatens youth health, calling it a "misconception" that the policy reduces harm. In contrast, addiction researcher Jakob Manthey, speaking to MDR Aktuell, advocated for "more scientific rigor" in cannabis policy debates.
<h2 class="wp-block-heading">All Eyes On The 2025 Evaluation</h2>
With legalization intact but its future uncertain, the upcoming 2025 evaluation will likely play a pivotal role in shaping Germany's long-term cannabis policy. The coalition has committed to keeping the assessment open-ended and evidence-based.
For now, cannabis cultivation clubs can continue operating, and personal use remains legal nationwide—except where limited by local restrictions. Germany's decision to stay the course provides a measure of stability to both patients and the emerging industry, even as the political discourse remains far from settled.
Photo: Shutterstock

Cannabis

Eurozone

Politics

Cannabis Stays Legal In Germany Following New Coalition Deal

CPRI

Capri Shares Resume Trading

Citigroup analyst Ryan Levine maintains Sempra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRE#NYSE">SRE</a>) with a Neutral and lowers the price target from $93 to $70.

Price Target

Citigroup Maintains Neutral on Sempra, Lowers Price Target to $70

AREB

American Rebel Shares Resume Trade

<a href="https://www.youtube.com/watch?v=3MUEruzKezo" title="https://www.youtube.com/watch?v=3MUEruzKezo">https://www.youtube.com/watch?v=3MUEruzKezo</a>

Macro Economic Events

Econ #s

Economics

U.S. Trade Representative Greer Says: Expects to See Handful Of Countries Open Markets To U.S. Exports, Which Will Help Make It Easier to Manufacture Products In U.S.;  U.S. Companies Will Become More Efficient When They Have Access To Overseas Markets; Trump's Power To Levy Tariffs Is Not Unlimited

BLIV

BeLive Shares Resume Trade

Citigroup analyst Ryan Levine maintains New Fortress Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) with a Buy and lowers the price target from $34 to $8.

Citigroup Maintains Buy on New Fortress Energy, Lowers Price Target to $8

Capri Shares Halted On Circuit Breaker To The Upside, Stock Now Up 5.05%

Capri Shares Resume Trade

Citigroup analyst Ryan Levine maintains Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) with a Buy and raises the price target from $116 to $120.

Citigroup Maintains Buy on Consolidated Edison, Raises Price Target to $120

WIIM

TRGP

Targa Resources shares are trading lower after Barclays maintained an Overweight rating on the stock and lowered its price target from $211 to $206.

While the consensus seems to underappreciate the trajectory of Johnson &amp; Johnson's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) Innovative Medicine business, Goldman Sachs says concerns around the Stelara loss of exclusivity appear overdone.
The Johnson &amp; Johnson Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/67f5483f584c820001291ac6/asad-haider">Analyst Asad Haider</a> upgraded the rating from Neutral to Buy, while raising the price target from $157 to $172.
The Johnson &amp; Johnson Thesis: While the Innovative Medicine business contributes around 65% of the company's revenues, it accounts for 83% of profits, which is why it is "more important for the materiality of the stock," Haider said in the upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Although the Stelara exclusivity is around the corner, Johnson &amp; Johnson has "numerous new product cycles across multiple large markets such as IBD, psoriasis, neuropsych, multiple myeloma, bladder cancer and EGFR mutated non-small-cell lung cancer," the analyst wrote.
Moreover, pharma stocks have historically troughed about a year ahead of a major loss of exclusivity, "which could bode well for JNJ if this pattern is followed," he added.
JNJ Price Action: Shares of Johnson &amp; Johnson had declined by 2.91% to $145.63 at the time of publication on Wednesday.
Read More: <a href="https://www.benzinga.com/25/04/44698946/cell-therapy-maker-legend-biotech-an-attractive-opportunity-in-unpredictable-times-analyst">&nbsp;Cell Therapy Maker Legend Biotech Is An &#8216;Attractive Opportunity&#8217; Due To No Material Tariff Exposure: Analyst</a>
Photo: Shutterstock

Upgrades

Movers

This Johnson & Johnson Analyst Turns Bullish On Shifting Focus From Stelara Concerns To Innovative Medicine

American Rebel Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Down -21.4%

Commodities

Press Releases

Bug Off Pest Control Center of New York City to Supply New York City with Evolve™

Small Cap

Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation

SenesTech Expands Global Footprint for Evolve Rodent Birth Control™: Signs Letter of Intent with SMark to Enter Indian Rodent Pest Control Market

SenesTech Expands E-Commerce Presence with Evolve Rodent Birth Control™ Now Available on TractorSupply.com

SenesTech Expands into Warehousing and Distribution Sector with Multi-Pallet Initial Shipment of Evolve Rodent Birth Control™

SenesTech Expands its Rapidly Growing Global Footprint and Clears Major Regulatory Hurdle, Paving the Way for Use in Australia and New Zealand

SenesTech to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Wednesday, March 12, 2025

Offerings

SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds

Earnings

SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA

SenesTech to Participate in the Lytham Partners 2025 Industrials & Basic Materials Investor Summit on April 1, 2025

Comments

SenesTech

SenesTech (SNES) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO